our-insights/
37 pages · Updated April 25, 2026
Pages
- our-insights/shareholder-representation/index.html
- our-insights/loan-agency/index.html
- our-insights/deal-terms-analysis/index.html
- What is a professional shareholder rep?
- State and Local Tax Changes for 2025
- Deal Terms Analysis
- Loan Documentation Tips
- Due Diligence
- Deal Sizes Surge as Private Equity Buyers Step Up Activity
- Tools for Practitioners
- Is RWI right for your M&A deal
- Deal Terms Analysis, Life Sciences
- Trends in Loan Documentation and Technology
- Key Insights from Road-tested Data
- **Key Findings**
- 2025 SRS Acquiom Life Sciences M&A Study
- 2025 Lower Middle-Market Deals Report
- 74%
- Explore the New Dynamic In Lending
- Payments, Indemnification
- M&A Deal Terms Study 2025 | Deal Points
- Is RWI the best option for your next M&A deal?
- Insights on Escrow in M&A Deals
- M&A Deal Protection with Expense Funds
- RWI findings from the 2025 M&A Deal Terms Study
- Kip Wallen
- M&A Working Capital Purchase Price Adjustment Study 2026
- What impact is private credit having on the syndicated loan market?
- A summary of the rise of SOFR, the de facto replacement lending rate to LIBOR, follows:
- Explore Key Earnout Achievement Insights
- Key Findings
- The Evolution of European Credit Markets
- The ABCs of LMTs (Liability Management Transactions)
- M&A Trends: 2026 Deal Terms Study
- Europe Turns to Direct Lending, Emerging Markets for Opportunities
- The Latest Outlook on Lending
- Private Credit’s Appeal Amid BSL Competition and Loosening Covenants